Pavlov George 4

4 · MapLight Therapeutics, Inc. · Filed Jun 25, 2026

AI-generated summary of this filing

Updated Jun 25, 2026

MapLight Therapeutics (MPLT) Director George Pavlov Receives RSU & Option Award

What Happened

George Pavlov, a director of MapLight Therapeutics (MPLT), was granted equity awards on June 23, 2026: 3,932 restricted stock units (RSUs) and a 14,902-share stock option (both recorded at $0.00).
These grants are director compensation — not open-market purchases or sales — so they reflect pay, not an independent buy/sell signal.

Key Details

Transaction date: June 23, 2026; Form 4 filed June 25, 2026 (timely filing).
Awards and amounts: 3,932 RSUs (each RSU = contingent right to one share) and a 14,902-share stock option (recorded as a derivative).
Vesting: Both the RSUs and the option vest on the earlier of (i) June 23, 2027 or (ii) the issuer’s next annual stockholder meeting, subject to the reporting person’s continuous service.
Source: Grants made under the Issuer’s 2025 Equity Incentive Plan and the company’s non-employee director compensation policy.
Shares owned after transaction: not disclosed in the filing.

Context

RSUs convert to actual shares only upon vesting; the option is a derivative that must vest (and typically be exercised) before shares are issued.
These are routine director compensation awards and involve no cash paid by the director at grant. They do not, by themselves, indicate the director bought or sold stock.

Form 4

Period: 2026-06-23

Director

Transactions

Award
Voting Common Stock
[F1][F2]
2026-06-23+3,932→ 28,932 total
Award
Stock Option (right to buy)
[F3]
2026-06-23+14,902→ 14,902 total
Exercise: $28.64Exp: 2036-06-22→ Voting Common Stock (14,902 underlying)

Footnotes (3)

[F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
[F2]Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
[F3]Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.

Signature

/s/ Kristopher L. Hanson, Attorney-in-Fact|2026-06-25

1 file